• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

MethodsX. A method for evaluating the cost-benefit of different preparedness planning policies against pandemic influenza

tetano

Editor, Senior Moderator
MethodsX. 2020 Mar 19;7:100870. doi: 10.1016/j.mex.2020.100870. eCollection 2020.
A method for evaluating the cost-benefit of different preparedness planning policies against pandemic influenza.


Panovska-Griffiths J[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3,[/SUP][SUP]4[/SUP], Grieco L[SUP]1[/SUP], van Leeuwen E[SUP]5,[/SUP][SUP]6[/SUP], Grove P[SUP]7[/SUP], Utley M[SUP]1[/SUP].

Author information




Abstract

•Our work presents a unifying method to calculate the net-benefit of different preparedness policies against different pandemic influeunza strains. Unlike previous methods, which have focused on evaluating specific strategies against specific pandemics, our method allows assessment of mass immunisation strategies in presence and absence of antiviral drugs for a large range of pandemic influenza strain characteristics and programme features. Overall, the model described here combines two parts to evaluate different preparedness planning policies against pandemic influenza.•The first part is adaptation of an existing transmission model for seasonal influenza to include generalisation across large number of pandemic influenza scenarios.•The second part is development of a tailor-made health economic model devised in collaboration with colleagues at the UK Department of Health and Social Care.
? 2020 The Author(s). Published by Elsevier B.V.



KEYWORDS:

Economic analysis; Epidemiological model; Pandemic influenza


PMID:32280602PMCID:PMC7139115DOI:10.1016/j.mex.2020.100870
Free full text
 
Back
Top Bottom